A US International Trade Commission ruling on gallium nitride (GaN) semiconductor patents has prompted conflicting victory claims from German chipmaker Infineon Technologies AG and its Chinese rival Innoscience (Guangzhou) Technology Co. Both companies saw their stock prices surge by more than 5% as each firm interpreted the outcome as a validation of its technology and market position. The dispute highlights the intense competition over GaN technology, which is critical for AI data centers and electric vehicles.
A US trade ruling has intensified the rivalry between Infineon and Innoscience for dominance in the gallium nitride (GaN) power semiconductor market, with both firms claiming victory and seeing their shares jump over 5 percent.
The US International Trade Commission (ITC) "issued its final ruling on the patent infringement case filed by Infineon against INNOSCIENCE," according to a research report from CLSA, which believed the outcome "demonstrates INNOSCIENCE's independent technological innovation capability."
The dueling interpretations sent both stocks higher on May 11. Infineon’s shares gained nearly 6% to close at a 10-year high of €62.11, while Innoscience stock rose 5.5% to HKD69.1. The ITC ruling found that of six patent claims, four were not infringed upon by Innoscience. The two claims found in violation relate to older products the company has already discontinued. Alongside the legal news, Infineon raised its adjusted free cash flow guidance for the fiscal year by €250 million to €1.65 billion.
The conflict centers on GaN, a semiconductor material that offers higher efficiency and power density than traditional silicon, making it vital for applications from AI data centers and electric vehicle chargers to renewable energy systems. The patent ruling gives teeth to Infineon's portfolio of roughly 450 GaN patent families, which the company sees as protecting it from a direct competitor in the critical US market.
Infineon framed the ITC decision as a "decisive ruling" that resulted in import and sales bans on the infringing Innoscience products in the US. The German firm's stock has surged more than 46% since the end of March, propelled by the legal win and an upgraded financial outlook. The company lifted its full-year segment result margin guidance to around 20% from a high-teens percentage previously. In response, analysts have raised their price targets, with Goldman Sachs lifting its target to €75, citing rising semiconductor demand from AI infrastructure.
Innoscience, however, stated the ruling has "no material impact on its US operations" because the two patents found to be in violation pertain only to legacy products. The company and its backers presented the outcome as a win, validating its intellectual property. Brokerage CLSA maintained its "Outperform" rating on Innoscience with a price target of HKD113.6, arguing the ruling affirms the company's independent innovation.
The dispute underscores the fierce competition in the broader semiconductor industry, which analysts increasingly see as being in a "supercycle" driven by massive demand for AI hardware. Processors used for AI require high-bandwidth memory and efficient power delivery systems where GaN technology excels. The battle for control over this foundational technology, as evidenced by the conflicting interpretations of the ITC ruling, highlights the high stakes as chipmakers fight for leadership in the next wave of computing.
This article is for informational purposes only and does not constitute investment advice.
